jlightner 
Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The trial required a patient population of generally healthy adults aged ≥50, stratified into three age groups. Challenge Vaccine season brings a surge of clinical research activity—especially for flu-related studies. At the time of this trial, several … Read more
Saint Louis, MO – Tekton Research is proud to announce its partnership with Dr. Ernest A. Graypel, a highly regarded psychiatrist and researcher, Board Certified in Psychiatry and Neurology. This effort supports Tekton’s expanding capabilities in central nervous system (CNS) research, particularly in Behavioral Health sciences. As the Medical Director of Community and Long-Term Care … Read more
As we step into 2025, Tekton Research is proud to reflect on a year filled with growth, innovation, and impactful contributions to clinical research. Tekton extends their gratitude to everyone who played a role in advancing their mission. From the dedicated staff and PI’s, to CRO and biopharma partners, and patients, who generously participated in … Read more
Marlboro, NJ – Tekton Research is pleased to announce that Amor R. Mehta, MD, a leading neurologist specializing in epilepsy, seizure disorders and neurodegenerative diseases, has joined the organization’s collaborative network. With a strong commitment to advancing epilepsy care and epilepsy-related neurodiagnostics in New Jersey, Dr. Mehta brings an unparalleled dedication to enhancing patient outcomes … Read more
Longmont, CO – Tekton Research, a prominent leader in clinical trials with a nationwide network of research facilities established in 2006, is excited to announce its recent partnership with Dr. Alex Reish. An esteemed osteopath specializing in migraines and chronic pain, Dr. Reish joins Tekton Research with a strong passion for innovative care and extensive … Read more
As flu season approaches, Tekton Research is conducting vital studies to enhance vaccine development and is seeking volunteers aged 50 and older to participate. These trials are essential for developing improved protections against the flu, which claims thousands of lives each year. Why This Research Matters “Flu kills thousands of people of all ages every … Read more
YUKON, OKLAHOMA —For more than a decade now, Tekton Research has never wavered from its focus of operating successful clinical trials across a network of clinical research locations throughout the United States. Tekton continues to grow, partnering with experienced research physicians, to pursue an investigative passion to uncover new information that may lead to discovering … Read more
Austin, TX – Tekton Research, a clinical research company focusing on clinical trials for pharmaceuticals and device companies, is excited to announce the appointment of Jeffrey Zucker as Vice President of Neurology Operations. In this role, Jeffrey will oversee commercial strategy, client outreach, site expansion, and other critical functions supporting all Neurology site locations. Jeffrey … Read more
AUSTIN, TX – Tekton Research, a clinical research company focusing on clinical trials for pharmaceuticals and device companies, is excited to announce the appointment of Bruce Wakeman as Chief Commercial Officer. With a distinguished career spanning the pharmaceutical and clinical research industries, Bruce brings a wealth of experience and a deep commitment to advancing patient-centric … Read more
Source:: Grace Smith – Wise News Network CHERRYVILLE, NC (WNN) – Clinical research opportunities have come to Cherryville, thanks to Tekton Research and Dr. Thomas White. Dr. White, a Cherryville native, has long sought to bring clinical trials to the residents of Cherryville and its surrounding areas. Tekton Research is a company dedicated to clinical … Read more